Document is current
Any future updates will be listed below
-
Authors
Mouri, Atsuto
Kaira, Kyoichi https://orcid.org/0000-0001-5548-7686
Yamaguchi, Ou
Hashimoto, Kosuke
Miura, Yu
Shiono, Ayako
Kawasaki, Tomonori
Kobayashi, Kunihiko
Imai, Hisao
Kagamu, Hiroshi
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (20K08118, 21K07627)
- License Information
-
More Information
Article History
Received: 1 May 2023
Accepted: 21 November 2023
First Online: 31 December 2023
Declarations
:
: KK received research grants and a speaker honorarium from Ono Pharmaceutical Company, Boehringer Ingelheim, Chugai Pharmaceutical, Taiho Pharmaceutical, Eli Lilly Japan, and AstraZeneca. AM received a speaker honorarium from Chugai Pharmaceutical, AstraZeneca, Merck Biopharma Company, Ono Pharmaceutical Company, Bristol-Myers Company, Novartis Pharma K.K., and Daiichi Sankyo Company. OY received speaker honorarium from Eli Lilly, Taiho Pharmaceutical, Pfizer, Chugai Pharmaceutical, and AstraZeneca. HK received research grants and a speaker honorarium from Ono Pharmaceutical Company, Bristol-Myers Company, Boehringer Ingelheim, MSD, Daiichi Sankyo Company, Chugai Pharmaceutical, Taiho Pharmaceutical, Merck Biopharma Company, Eli Lilly Japan, and AstraZeneca. HI received research grants and a speaker honorarium from Ono Pharmaceutical Company, AstraZeneca, and Bristol-Myers Company.
